Wall Street returns to trading today after the extended Labor Day weekend, with the market having had several days to digest a significantly stronger-than-expected U.S. jobs report. On Friday, nonfarm payrolls increased by 162,000, compared with expectations of just 55,000, while the unemployment rate came in at 4.1%. Such strong data clearly changed expectations for Fed policy and pushed the probability of a rate hike in September to around 60%.
The second week of September will therefore be primarily about answering the question of whether a strong labor market is actually forcing the Fed to take a more decisive approach. The macroeconomic calendar is particularly important this week. On Thursday, investors will receive the latest producer price inflation (PPI) data, followed a day later by the more important Consumer Price Index (CPI). These readings will be particularly significant because, following Friday’s NFP report, any signs that price pressures remain elevated could further increase expectations of a rate hike.
Oil prices are also once again at the center of attention. Rising tensions in the Middle East and the situation around the Strait of Hormuz have pushed Brent crude toward $100 per barrel, further complicating the Fed’s position. Higher energy prices not only increase costs across the economy but also create the risk of renewed inflationary pressure. This means markets now have to consider both a strong labor market and the possibility of an energy shock at the same time.
However, even a higher-than-expected CPI reading may not necessarily change this view, particularly if most of the inflationary pressure is driven by a sharp rise in energy prices. The Fed may choose to wait out the shock and assess whether it proves temporary rather than responding immediately to a single set of data.
As a result, the coming days could bring increased volatility to Wall Street. Investors will be closely watching oil prices, U.S. Treasury yields and the latest inflation data as they try to determine whether a September rate hike is genuinely becoming a realistic scenario or whether current expectations have simply become too aggressive.
Source: XTB Research
Futures on the S&P 500 (US500) are currently hovering around the reference level with no clear direction, while investors remain cautious ahead of new market catalysts. Inflation data due later this week will undoubtedly attract significant attention. The readings could have an important impact on expectations for the Fed’s next decisions and the direction of the U.S. stock market.
Source: xStation5
Company News
Intel (INTC.US) shares are rising strongly following more positive assessments of the company’s outlook and reports of potential price increases. The improvement is being supported by progress in the company’s turnaround, continued shortages of server processors and potential benefits from its cooperation with Tesla on the Terafab project, which could further support the development of Intel’s manufacturing business.
Qualcomm (QCOM.US) has partnered with Amazon to develop new solutions for data centers used to support artificial intelligence. The cooperation could help Qualcomm strengthen its position in the rapidly growing AI market and expand its presence beyond its traditional smartphone business.
GE Aerospace (GE.US) plans to acquire a company that manufactures components for aircraft engines for approximately $12 billion. The deal is intended to give GE greater control over the production of key components and help the company prepare for growing demand for aircraft and replacement parts.
PepsiCo (PEP.US) is expanding beyond its traditional snacks and beverages business, with a greater focus on fresh and refrigerated food, ready-to-eat meals and products sold in other parts of grocery stores. The company is adapting its offering to changing consumer habits, including the growing popularity of GLP-1 medications.
Bristol Myers Squibb (BMY.US) reported positive results from trials of a new therapy for one type of blood cancer. The results increase the chances of further development of the treatment and could strengthen the company’s position in the cancer treatment market in the future.
🚩 Cocoa futures down 3.5% as ICE inventories rise to 2-year high
ASML is picking up pace again.
Novartis shares fall the most since 2020 📉 What is behind the 10% decline?
🛢️Brent Crude Nearing $100
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.